Blueprint Medicines Overview

Blueprint Medicines Gross Profit

Gross Profit analysis for BPMC.

Quarterly Gross Profit

$146.61M

↑ 66.39% YoY

As of Mar 31, 2025

Annual Gross Profit (TTM)

$542.35M

↑ 104.24% YoY

Trailing 12 months ending Mar 31, 2025

Average Gross Profit (Comparison Companies)

Gross Profit History

Gross Profit Comparison

Annual Gross Profit Growth Rate (%)

Annual Gross Profit Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin